Anixa Current Assets vs Operating Income Analysis
ANIX Stock | USD 3.12 0.02 0.65% |
Trend analysis of Anixa Biosciences balance sheet accounts such as Other Current Liab of 2.1 M, Total Current Liabilities of 2.4 M or Total Stockholder Equity of 29.4 M provides information on Anixa Biosciences' total assets, liabilities, and equity, which is the actual value of Anixa Biosciences to its prevalent stockholders. By breaking down trends over time using Anixa Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Anixa |
About Anixa Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Anixa Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Anixa Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Anixa Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Anixa currently owns. An asset can also be divided into two categories, current and non-current.
Anixa Biosciences Balance Sheet Chart
Anixa Biosciences Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Anixa Biosciences uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Anixa Biosciences' Property Plant Equipment is fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 35.1 M in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 132.1 K in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Anixa Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anixa Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Anixa Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Anixa Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most indicators from Anixa Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.Sales General And Administrative To Revenue is likely to rise to 28.31 in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.
Anixa Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Anixa Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anixa Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.5M | 36.3M | 30.4M | 25.5M | 29.4M | 30.8M | |
Other Current Liab | 901.0K | 1.1M | 1.7M | 1.8M | 2.0M | 2.1M | |
Total Current Liabilities | 1.2M | 1.3M | 2.0M | 2.0M | 2.3M | 2.4M | |
Total Stockholder Equity | 8.8M | 35.4M | 29.0M | 24.3M | 28.0M | 29.4M | |
Property Plant And Equipment Net | 54.3K | 254.0K | 212K | 166K | 149.4K | 132.1K | |
Net Debt | (6.4M) | (28.9M) | (12.1M) | (740K) | (666K) | (699.3K) | |
Retained Earnings | (191.8M) | (204.8M) | (218.4M) | (228.2M) | (205.4M) | (195.1M) | |
Cash | 6.4M | 29.1M | 12.4M | 915K | 1.1M | 999.6K | |
Non Current Assets Total | 84.3K | 254.0K | 212K | 166K | 190.9K | 181.4K | |
Cash And Short Term Investments | 9.1M | 35.7M | 29.7M | 23.8M | 27.4M | 28.8M | |
Common Stock Shares Outstanding | 22.2M | 28.6M | 30.4M | 31.0M | 35.6M | 37.4M | |
Liabilities And Stockholders Equity | 9.5M | 36.3M | 30.4M | 25.5M | 29.4M | 30.8M | |
Other Current Assets | 2.9M | 6.9M | 513K | 1.2M | 1.4M | 897.9K | |
Other Stockholder Equity | 200.4M | 239.9M | 247.1M | 252.2M | 290.1M | 304.6M | |
Total Liab | 1.2M | 1.5M | 2.2M | 2.2M | 2.5M | 2.2M | |
Property Plant And Equipment Gross | 54.3K | 254.0K | 212K | 166K | 149.4K | 132.1K | |
Total Current Assets | 9.4M | 36.0M | 30.2M | 25.4M | 29.2M | 30.6M | |
Non Currrent Assets Other | 910.2K | (200.6K) | 30K | (212K) | (243.8K) | (231.6K) | |
Net Receivables | 66.5K | 2.2K | 46K | 270K | 243K | 231.6K | |
Accounts Payable | 232.4K | 136.2K | 265K | 206K | 185.4K | 176.1K | |
Non Current Liabilities Total | 287.6K | 220.1K | 175K | 123K | 141.5K | 134.4K | |
Common Stock Total Equity | 189.1K | 203.3K | 242.5K | 309K | 278.1K | 264.2K | |
Short Term Investments | 2.6M | 6.6M | 17.3M | 22.9M | 26.4M | 27.7M | |
Common Stock | 242.5K | 300.5K | 309K | 311K | 279.9K | 265.9K | |
Property Plant Equipment | 200.6K | 54.3K | 254.0K | 212K | 243.8K | 256.0K | |
Net Tangible Assets | 5.2M | 8.8M | 35.4M | 29.0M | 33.4M | 35.1M | |
Noncontrolling Interest In Consolidated Entity | (251.4K) | (423.0K) | (497.0K) | (847K) | (762.3K) | (724.2K) | |
Retained Earnings Total Equity | (170.2M) | (181.8M) | (191.8M) | (218.4M) | (196.5M) | (206.4M) | |
Capital Surpluse | 175.4M | 186.8M | 200.4M | 247.1M | 284.2M | 181.1M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Anixa Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Anixa Biosciences' short interest history, or implied volatility extrapolated from Anixa Biosciences options trading.
Pair Trading with Anixa Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anixa Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Anixa Stock
0.79 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
0.79 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
0.68 | ZNTL | Zentalis PharmaceuticalsL Buyout Trend | PairCorr |
0.64 | JSPRW | Jasper Therapeutics | PairCorr |
0.62 | MRSN | Mersana Therapeutics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Anixa Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anixa Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anixa Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anixa Biosciences to buy it.
The correlation of Anixa Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anixa Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anixa Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anixa Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Anixa Stock analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share 0.007 | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.